Stockreport

Regeneron (REGN) Is Up 5.4% After New Myeloma Data And Gene Writing Tie-Up With Tessera [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Lynozyfic™ (linvoseltamab), advanced a broad early-stage program in newly diagnosed patients, and entered a global collaboration with Tessera Therapeutics to develop TSR [Read more]